Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Helsingborg – page 24

1 322 clinical trials in Helsingborg, Sweden. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Helsingborg at a glance
1 322
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 322 trials in Helsingborg

Open in trial search

Study on the Effects of Pitolisant Hydrochloride for Patients with Prader-Willi Syndrome

Investigational
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Pitolisant hydrochloride
  • Sponsor:Harmony Biosciences LLC

Study on Colchicine and Aspirin for Improving Heart Health in Adults with Type 2 Diabetes Without Previous Heart Events

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Carbasalate Calcium
  • Sponsor:Montreal Heart Institute

Study on Using Dapagliflozin, Semaglutide, and Finerenone to Prevent Heart and Kidney Complications in Patients with Type 2 Diabetes

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Steno Diabetes Center Copenhagen

Study Comparing Lomustine Alone and Lomustine with Bevacizumab for Patients with Recurrent Glioblastoma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Region Hovedstaden

Study on the Effectiveness of Tenecteplase in Patients with Acute Ischemic Stroke Taking Rivaroxaban, Apixaban, or Edoxaban

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Alteplase
  • Sponsor:Oslo University Hospital HF

Study on Revumenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Study Comparing Electrochemotherapy with Bleomycin to Standard Radiotherapy for Treating Basal Cell Carcinoma in Patients with Tumors Less Than 3 cm

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bleomycin
  • Sponsor:Region Hovedstaden

Study on Preventing Agitation After Anesthesia in Children Aged 1 Year or Younger Using Clonidine Hydrochloride and Sodium Chloride

Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Sodium Chloride
  • Sponsor:Region Hovedstaden

Study on Imaging and Treatment Prediction for Metastatic Breast Cancer Using Gallium (68Ga) Tezatabep Matraxetan and Trastuzumab Deruxtecan

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Gallium (68GA) tezatabep matraxetan
  • Sponsor:Karolinska University Hospital

Study Comparing Chemotherapy Options for Patients with Stage I Testicular Cancer: Bleomycin, Etoposide, Cisplatin vs. Carboplatin

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Bleomycin
  • Sponsor:St. Olavs Hospital HF

Study of TCR-Modified T Cell Therapy with ANOC-001, ANOC-002, and ANOC-003 for Adults with Advanced Pancreatic Cancer

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:ANOC-001
  • Sponsor:Anocca AB

Study on Rituximab, Lenalidomide, and Tafasitamab for Treating High-Risk and Low-Risk Follicular Lymphoma Patients

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide
  • Sponsor:Karolinska University Hospital

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Helsingborg

What the registry says about research in the country

01 Cardiovascular Research

Innovative studies exploring treatments for heart failure and cardiovascular conditions, including research on combination therapies to reduce cardiovascular mortality.

  • Heart Failure Prevention
  • Atrial Fibrillation
  • Takotsubo Syndrome

Groundbreaking trials evaluating novel drug combinations and therapeutic approaches for cardiac conditions.

02 Oncology Studies

Advanced research focusing on multiple myeloma treatment, particularly for patients with relapsed or refractory conditions.

  • Blood Cancer Therapies
  • Combination Treatment Approaches
  • Bladder Cancer Management

Evaluating innovative therapeutic combinations and comparing effectiveness of different treatment regimens.

03 Infectious Diseases

Clinical investigations into treatments for various infections, including bacterial infections and antibiotic resistance.

  • Staphylococcus Aureus Treatment
  • Urinary Tract Infections
  • Viral Lung Infections

Studies focusing on alternative antibiotics and novel approaches to combat resistant infections.

04 Mental Health Research

Studies examining innovative treatments for psychiatric disorders, including treatment-resistant conditions.

  • Schizophrenia Spectrum Disorders
  • Treatment-Resistant Depression
  • Novel Therapeutic Approaches

Investigating immunomodulatory treatments and new compounds for mental health conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.